Table 3.
Differing minimum inhibitory concentration antimicrobial susceptibilities for S. aureus
| Study ID | PEN | OX/ME | CEFO | CIP | ENO | MBO | CLN | DX | FLOR |
|---|---|---|---|---|---|---|---|---|---|
| A1 | 0.12 | 0.5 | 2 | R | >4 | >4 | 0.25 | R | 8 |
| A2 | 0.06 | <0.25 | 1 | R | >4 | >4 | 0.25 | <0.12 | <4 |
| B1 | 0.12 | <0.25 | 2 | S | <0.5 | <0.5 | 0.25 | <0.12 | 8 |
| B2 | 0.06 | <0.25 | 2 | S | <0.5 | <0.5 | 0.25 | <0.12 | <4 |
| D1 | 0.12 | <0.25 | 1 | R | >4 | >4 | 0.25 | 0.25 | <4 |
| D2 | 0.06 | <0.25 | 1 | R | >4 | >4 | 0.25 | <0.12 | <4 |
| G1 | 0.12 | <0.25 | 2 | S | <0.5 | <0.5 | 0.25 | <0.12 | <4 |
| G2 | 0.12 | 0.5 | 2 | S | <0.5 | <0.5 | 0.25 | <0.12 | <4 |
| L1 | <0.03 | <0.25 | 1 | S | <0.5 | <0.5 | <0.12 | <0.12 | <4 |
| L2 | 0.12 | 0.5 | 2 | S | <0.5 | <0.5 | 0.25 | <0.12 | 8 |
| P1 | 0.12 | 0.5 | 2 | S | <0.5 | <0.5 | 0.25 | 0.25 | <4 |
| P2 | 0.12 | 0.5 | 2 | S | <0.5 | <0.5 | 0.25 | <0.12 | <4 |
| S1 | 0.12 | <0.25 | 2 | S | <0.5 | <0.5 | 0.25 | <0.12 | <4 |
| S2 | 0.12 | 0.5 | 2 | S | <0.5 | <0.5 | <0.12 | <0.12 | <4 |
| T1 | 0.12 | <0.25 | 2 | S | <0.5 | <0.5 | 0.25 | <0.12 | <4 |
| T2 | 0.12 | 0.5 | 2 | S | <0.5 | <0.5 | 0.25 | <0.12 | <4 |
Prestudy isolates are designated with the number 1 following the animal ID and poststudy isolates are designated with the number 2 following the animal ID. Unshaded MICs indicate susceptibility, yellow-shaded MICs indicate intermediate susceptibility, and red-shaded MICs indicate resistant susceptibilities. When numeric MICs were not provided, S and R are used to designate susceptible and resistant results, respectively. Key: PEN, penicillin; OX/ME, oxacillin/methicillin; CEFO, cefovecin; CIP, ciprofloxacin; ENO, enrofloxacin; MBO, marbofloxacin; CLN, clindamycin; DX, doxycycline; FLOR, florfenicol. In addition, all isolates were susceptible to amoxicillin (>0.25), amoxicillin-clavulanic acid (>0.25), imipenem (S), cephalexin (>2), cefpodoxime (>2), amikacin (>2), gentamicin (>0.5), azithromycin (S), erythromycin (>0.25), mupirocin (>1), chloramphenicol (>4), TMS (>10), minocycline (>0.5), and rifampin (>0.03).